| Trial ID: | L0462 |
| Source ID: | NCT00767897
|
| Associated Drug: |
Human Papillomavirus Vaccine
|
| Title: |
The Impact of the Human Papilloma Virus in Pediatric Chronic Kidney Disease, Dialysis, and Transplant Patients
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease|Dialysis
|
| Interventions: |
DRUG: Human Papillomavirus Vaccine
|
| Outcome Measures: |
|
| Sponsor/Collaborators: |
Sponsor: Indiana University | Collaborators: Merck Sharp & Dohme LLC|National Kidney Foundation
|
| Gender: |
FEMALE
|
| Age: |
CHILD, ADULT
|
| Phases: |
|
| Enrollment: |
72
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2011-11
|
| Completion Date: |
2018-12
|
| Results First Posted: |
|
| Last Update Posted: |
2024-03-29
|
| Locations: |
Indiana University/Riley Children's Hospital, Indianapolis, Indiana, 46202, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00767897
|
